136 related articles for article (PubMed ID: 38215731)
1. MOF@COF Nanocapsules Enhance Soft Tissue Sarcoma Treatment: Synergistic Effects of Photodynamic Therapy and PARP Inhibition on Tumor Growth Suppression and Immune Response Activation.
Tai Y; Chen Z; Luo T; Luo B; Deng C; Lu Z; Wen S; Wang J
Adv Healthc Mater; 2024 Apr; 13(11):e2303911. PubMed ID: 38215731
[TBL] [Abstract][Full Text] [Related]
2. Molecular signatures of BRCAness analysis identifies PARP inhibitor Niraparib as a novel targeted therapeutic strategy for soft tissue Sarcomas.
Li H; Tu J; Zhao Z; Chen L; Qu Y; Li H; Yao H; Wang X; Lee DF; Shen J; Wen L; Huang G; Xie X
Theranostics; 2020; 10(21):9477-9494. PubMed ID: 32863940
[No Abstract] [Full Text] [Related]
3. Combination of talaporfin photodynamic therapy and Poly (ADP-Ribose) polymerase (PARP) inhibitor in gastric cancer.
Tanaka M; Sasaki M; Suzuki T; Nishie H; Kataoka H
Biochem Biophys Res Commun; 2021 Feb; 539():1-7. PubMed ID: 33388624
[TBL] [Abstract][Full Text] [Related]
4. π-Extended Benzoporphyrin-Based Metal-Organic Framework for Inhibition of Tumor Metastasis.
Zeng JY; Zou MZ; Zhang M; Wang XS; Zeng X; Cong H; Zhang XZ
ACS Nano; 2018 May; 12(5):4630-4640. PubMed ID: 29584395
[TBL] [Abstract][Full Text] [Related]
5. Monodispersed CuSe Sensitized Covalent Organic Framework Photosensitizer with an Enhanced Photodynamic and Photothermal Effect for Cancer Therapy.
Hu C; Zhang Z; Liu S; Liu X; Pang M
ACS Appl Mater Interfaces; 2019 Jul; 11(26):23072-23082. PubMed ID: 31252509
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors.
Mangoni M; Sottili M; Salvatore G; Meattini I; Desideri I; Greto D; Loi M; Becherini C; Garlatti P; Delli Paoli C; Dominici L; Gerini C; Scoccianti S; Bonomo P; Silvano A; Beltrami G; Campanacci D; Livi L
Radiat Res; 2018 Nov; 190(5):464-472. PubMed ID: 30067444
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable oxygen-producing manganese-chelated metal organic frameworks for tumor-targeted synergistic chemo/photothermal/ photodynamic therapy.
Feng L; Chen M; Li R; Zhou L; Wang C; Ye P; Hu X; Yang J; Sun Y; Zhu Z; Fang K; Chai K; Shi S; Dong C
Acta Biomater; 2022 Jan; 138():463-477. PubMed ID: 34718179
[TBL] [Abstract][Full Text] [Related]
8. Ultra-stable MOF@MOF nanoplatform for photodynamic therapy sensitized by relieved hypoxia due to mitochondrial respiration inhibition.
Yu J; Li Q; Wei Z; Fan G; Wan F; Tian L
Acta Biomater; 2023 Oct; 170():330-343. PubMed ID: 37607616
[TBL] [Abstract][Full Text] [Related]
9. Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy.
He H; Du L; Xue H; Wu J; Shuai X
Acta Biomater; 2022 Sep; 149():297-306. PubMed ID: 35811069
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of Au@MOF core-shell hybrids for enhanced photodynamic/photothermal therapy.
Cai X; Zhao Y; Wang L; Hu M; Wu Z; Liu L; Zhu W; Pei R
J Mater Chem B; 2021 Sep; 9(33):6646-6657. PubMed ID: 34369551
[TBL] [
